Exiqon, MultiD Reach Software Deal | GenomeWeb

Bya GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exiqon and MultiD Analyses today announced a development and distribution agreement incorporating a specifically adapted version of MultiD's GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform.

As a result of the deal, Exiqon will now be able to sell a fully compatible and comprehensive data analysis solution to complete its microRNA qPCR offering, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.